Blood volume expander gets FDA nod
Voluven is approved for blood loss
Voluven, manufactured by German company Fresenius Kabi, has received an FDA approval for restoring blood volume following surgery. The new intravenous product contains 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection and has proven to be as safe and effective in expanding blood volume as Hespan (B. Braun Medical) during orthopedic surgery. The new solution was also studied in newborns and infants. The synthetic starch molecules contained in the product do not dissolve in water and are linked together and combined with a salt solution in a concentration similar to human blood. According to the company, a clinical trial to study Voluven in patients with sepsis is planned.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
